KRASG12D-targeted therapy sensitivity depends on interferon signaling activation in pancreatic cancer
Cancer Cell · 2026-11 · 44 (11) · 2305-2323.e10
DOI: 10.1016/j.ccell.2026.10.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2026-11. Verfasst von Yehan Zhang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Multi-Cell Systems, Shanghai Key Laboratory of Molecular Andrology, Shanghai Institute of Biochemistry and Cell Biology, Center for…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Proto-Oncogene Proteins p21(ras), Interferon-beta, Interferons. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Education Commission, Shanghai Municipal Health Commission.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Multi-Cell Systems, Shanghai Key Laboratory of Molecular Andrology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Sh…
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
- Department of Laboratory Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China; College of Health Science and Technology, Shanghai Jiao Tong University School of M…
- Department of Hepatobiliary Pancreatic Surgery, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai 200433, China.
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China. Electronic address: wzjtcy@126.com.
- Department of Hepatobiliary Pancreatic Surgery, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai 200433, China. Electronic address: jingang@smmu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Shanghai Municipal Education Commission
- Shanghai Municipal Health Commission
- Chinese Academy of Sciences
- Ministry of Science and Technology of the People's Republic of China
- National Health Commission of the People's Republic of China
Zitieren
APA
Zhang, Y., Tang, S., Zhang, Y., Liu, J., Shi, X., Li, Y., Li, Y., Wang, H., Zhong, C., Sun, M., Li, W., Zhu, Y., Yang, W., Zhao, Y., Guo, S., Wu, Z., Wang, L., Jin, G., & Gao, D. (2026). KRASG12D-targeted therapy sensitivity depends on interferon signaling activation in pancreatic cancer. Cancer Cell, 44(11), 2305-2323.e10. https://doi.org/10.1016/j.ccell.2026.10.003
Vancouver
Zhang Y, Tang S, Zhang Y, Liu J, Shi X, Li Y, et al. KRASG12D-targeted therapy sensitivity depends on interferon signaling activation in pancreatic cancer. Cancer Cell. 2026;44(11):2305-2323.e10. doi:10.1016/j.ccell.2026.10.003
BibTeX
@article{Zhang2026,
author = {Zhang, Yehan and Tang, Shijie and Zhang, Yi and Liu, Jiahui and Shi, Xiaohan and Li, Yikai and Li, Yunguang and Wang, Huan and Zhong, Chaoliang and Sun, Maoyuan and Li, Wenjie and Zhu, Yiqin and Yang, Weiwei and Zhao, Yun and Guo, Shiwei and Wu, Zhongjun and Wang, Lin and Jin, Gang and Gao, Dong},
title = {KRASG12D-targeted therapy sensitivity depends on interferon signaling activation in pancreatic cancer},
journal = {Cancer Cell},
year = {2026},
volume = {44},
number = {11},
pages = {2305--2323.e10},
doi = {10.1016/j.ccell.2026.10.003}
}
EUVIMED